# Evaluating the Safety and Efficacy Civamide in Osteoarthritis (OA) of the Knee(s)

> **NCT00995306** · PHASE3 · COMPLETED · sponsor: **Winston Laboratories** · enrollment: 695 (actual)

## Conditions studied

- Osteoarthritis of the Knee

## Interventions

- **DRUG:** Civamide (Zucapsaicin)

## Key facts

- **NCT ID:** NCT00995306
- **Lead sponsor:** Winston Laboratories
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-06
- **Primary completion:** 2004-04
- **Final completion:** 2004-06
- **Target enrollment:** 695 (ACTUAL)
- **Last updated:** 2011-06-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00995306

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00995306, "Evaluating the Safety and Efficacy Civamide in Osteoarthritis (OA) of the Knee(s)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00995306. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*